Alexza Pharma (ALXA) Reports Q4 Loss of $0.15/Share; Warns it May Shut Down

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Alexza Pharma (ALXA) Reports Q4 Loss of $0.15/Share; Warns it May Shut Down

Alexza Reports Fourth Quarter and Year End 2015 Financial Results

March 28, 2016 4:10 PM EDT

MOUNTAIN VIEW, Calif., March 28, 2016 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza", or the "Company") today reported financial results for the quarter and year ended December 31, 2015.  The net loss for the fourth quarter was $3.0 million compared to $6.7 million during the same quarter in 2014.  The net loss for the years ended December 31, 2015 and 2014 was $21.3 million and $36.7 million, respectively.  At December 31, 2015, Alexza had consolidated cash and cash equivalents of $7.8 million.

"We continue our efforts to increase the value of ADASUVE, our pipeline and of Alexza," said Thomas B. King, President and CEO of Alexza Pharmaceuticals.  "In... More